Home/Filings/4/0000950170-25-037068
4//SEC Filing

Witzeman Michael D 4

Accession 0000950170-25-037068

CIK 0000019584other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 3:12 PM ET

Size

8.3 KB

Accession

0000950170-25-037068

Insider Transaction Report

Form 4
Period: 2025-03-10
Witzeman Michael D
VP & Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy with tandem tax withholding)

    2025-03-10$445.35/sh8,796$3,917,29934,484 total
    Exercise: $445.35Exp: 2026-10-28Capital Stock (8,796 underlying)
  • Exercise/Conversion

    Capital Stock

    2025-03-10$445.35/sh+8,796$3,917,29913,154 total
  • Tax Payment

    Capital Stock

    2025-03-10$600.92/sh7,494$4,503,2945,660 total
Footnotes (2)
  • [F1]Payment of purchase price and tax obligation on stock option exercise.
  • [F2]Vesting in three equal annual installments commencing 10/28/2022

Documents

1 file

Issuer

CHEMED CORP

CIK 0000019584

Entity typeother

Related Parties

1
  • filerCIK 0001699624

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 3:12 PM ET
Size
8.3 KB